Myeongin Benztropine Mesylate Tablet 2 mg

Adult dosage

(Oral: tablets) Adults: The initial dose is 0.5-1㎎ of benztropine mesylate daily, administered orally. Thereafter, gradually increase the dose by 0.5㎎ daily at intervals of 5-6 days until the maintenance dose is reached. Determine the maintenance dose based on improvement in symptoms and the occurrence of adverse effects, and do not exceed 6㎎ daily. Adjust the dose as appropriate according to age and symptoms. (Injection) ○ Adults 1. The initial dose is 0.5-1㎎ of benztropine mesylate daily, administered intramuscularly or intravenously. Thereafter, gradually increase the dose by 0.5㎎ daily at intervals of 5-6 days until the maintenance dose is reached. Determine the maintenance dose based on improvement in symptoms and the occurrence of adverse effects, and do not exceed 6㎎ daily. 2. In an emergency, inject 1-2㎎ of this drug to relieve symptoms, then administer 1-2㎎ orally twice daily to prevent recurrence. The injection should be administered intramuscularly or intravenously in emergencies or when oral administration is not possible. Adjust the dose as appropriate according to age and symptoms.

This drug should not be used in patients with glaucoma, those who are hypersensitive to this drug, patients with myasthenia gravis, and infants under 3 years of age. Additionally, as this drug contains lactose, it should not be administered to patients with genetic disorders such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption. Patients with urinary obstructive diseases such as benign prostatic hyperplasia, those with arrhythmias or tachycardia, individuals with impaired liver or kidney function, elderly persons, children over 3 years old, and those in hot environments should use this drug cautiously. When taking this medication, one should be aware that symptoms such as mental confusion, hallucinations, altered consciousness, anxiety, and depression may occur. In the gastrointestinal system, symptoms such as dry mouth, nausea, vomiting, and constipation may arise, while in the urinary system, urinary difficulty or urinary retention may occur. Additionally, if skin rash or hypersensitivity reactions appear, the medication should be discontinued, and visual disturbances may occur. When starting the medication, the dosage should be gradually increased from a small amount, and this should also be done cautiously when switching from another drug to this one. It is advisable to have regular eye examinations and intraocular pressure checks during treatment. Unlike certain other antiparkinsonian agents, this medication may not relieve some involuntary movement symptoms and may even worsen them. While taking this medication, attention and reflexes may be impaired, so one should avoid driving or operating dangerous machinery. Additionally, the effect may be enhanced when taken with phenothiazine medications, tricyclic antidepressants, MAO inhibitors, and reserpine derivatives, so caution is required. Severe intestinal paralysis symptoms may occur when taken with anticholinergic drugs, and if such symptoms arise, the medication should be discontinued. It is safest for women who are pregnant or may become pregnant, as well as for nursing mothers, to avoid taking this medication.

• Ataxia
• delirium
• hallucinations
• consciousness disturbances
• delirium
• neural hyperactivity
• agitation
• anxiety
• depression
• lethargy

This medication may be sensitive to light, so it should be stored in a container that blocks light. Additionally, it should be stored in a tightly sealed container to maintain the drug's efficacy and prevent degradation.

Appearance

White round tablets

Package unit

1000 tablets/bottle